AstraZeneca and European Commission COVID-19 vaccine agreement
AstraZeneca has concluded an agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine. This is...
Long-term COVID-19 symptoms in patients and doctors
Data released today as part of the BMA’s latest survey of doctors during the pandemic reveals significant levels of long-term COVID-19 symptoms in patients...
‘One Million’ study to monitor COVID-19 vaccine safety and effectiveness
A UK consortium has announced plans for a 'One Million' Post-Authorisation Study to monitor the safety and effectiveness of the COVID-19 vaccine in real-life...
Roll out of rapid coronavirus tests ahead of winter
Millions of rapid coronavirus tests will be rolled out to hospitals, care homes and labs across the UK to increase testing capacity ahead of...
COVID-19: Pharma on the frontline
Pharma stepped up to support the NHS, the country and the World during the COVID-19 pandemic. Pf brings you some examples of pharma on...
Opportunity to transform NHS customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, talks about the impact of coronavirus on NHS customer engagement. As the first wave of COVID-19 subsides in...
Health Technology Assessment Post-COVID
Claudia Rubin, Director at Decideum, questions what will Health Technology Assessment look like post-COVID? As England and the devolved nations emerge from COVID-19 lockdown at...
Rapid change COVID-19 & UK clinical research
Dr Matthew Hallsworth, Head of External Relations at the National Institute for Health Research, looks how COVID-19 has brought about rapid change of clinical...
Accelerated use of electronic prescribing
Deborah Evans, Managing Director of Pharmacy Complete, looks at the instruction to stay at home, GP surgeries closing their doors and consumers rethinking how...
Remote engagement with HCPs after COVID-19
Mick O’Leary, Regional President of Ashfield Commercial and Patient Solutions, looks at how the pharmaceutical industry can create a vision for the ‘new normal’...
Latest articles
New COVID-19 screening technology could test large groups with rapid response
The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...
Distribution and scaling up a Covid-19 vaccine
The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
Distribution and scaling up a Covid-19 vaccine
The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...
New COVID-19 screening technology could test large groups with rapid response
The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...